Grant: Collaborative Health Research Projects
University of Toronto
$88,000.00
High-throughput sperm motility assay and automated selection for clinical in vitro fertilization
FY 2012-13
Summary
This proposal describes the development and application of a high-throughput sperm physiological motility
measurement to: (1) quantify the correlation between sperm motility and DNA integrity; (2) correlate the
tendency of sperm to swim near vessel walls with sperm viability; and (3) apply these findings to screen
candidate sperm for the clinical application of in vitro fertilization (IVF). The project contains three iterative
segments of device development, initial testing, and human sperm based testing, followed by implementation at
the OVO Fertility Clinic.
In Canada, one in six couples experience fertility issues and each year an estimated 3500 live births
involve assisted reproductive technologies, most notably IVF. Current techniques of semen processing and
sperm selection are crude and differ greatly from the natural process in vivo. Moreover, these techniques may
be ineffective in selecting the best spermatozoa and, may result in iatrogenic damage to the sperm, including
the sperm DNA. Sperm DNA damage is associated with reduced IVF pregnancy rates, increased risk of
pregnancy loss after IVF, and compromised health of offspring. This project addresses the critical need for a
clinically-viable, sperm selection method that avoids technician error, cell trauma, oxidative stress, and DNA
damage while reflecting as much as possible the natural in vivo process.
This project is a new collaboration enabled through the CHRP opportunity. The project brings together
engineering and male and female fertility health researchers, and IVF treatment providers at the OVO Fertility
Clinic. This work will lead to: (1) a new understanding of the fundamental characteristics of human sperm
motility; (2) sperm transport modes and metrics as indicators of sperm viability; (3) the application of these
findings at the clinical-level to the benefit of infertile couples and offspring; (4) new commercialization
opportunities for Canadian industry; and (5) highly qualified personnel with the multidisciplinary skills needed
to develop next-generation fertility treatments.
Program
Collaborative Health Research Projects
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
399337-2011
Name nom
Sinton, David
Department département
Mechanical and Industrial Engineering
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2011
Award amount
88000
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Partie
2
Nb partie
3
Application title
High-throughput sperm motility assay and automated selection for clinical in vitro fertilization
Keyword
NSERC
Application summary
This proposal describes the development and application of a high-throughput sperm physiological motility
measurement to: (1) quantify the correlation between sperm motility and DNA integrity; (2) correlate the
tendency of sperm to swim near vessel walls with sperm viability; and (3) apply these findings to screen
candidate sperm for the clinical application of in vitro fertilization (IVF). The project contains three iterative
segments of device development, initial testing, and human sperm based testing, followed by implementation at
the OVO Fertility Clinic.
In Canada, one in six couples experience fertility issues and each year an estimated 3500 live births
involve assisted reproductive technologies, most notably IVF. Current techniques of semen processing and
sperm selection are crude and differ greatly from the natural process in vivo. Moreover, these techniques may
be ineffective in selecting the best spermatozoa and, may result in iatrogenic damage to the sperm, including
the sperm DNA. Sperm DNA damage is associated with reduced IVF pregnancy rates, increased risk of
pregnancy loss after IVF, and compromised health of offspring. This project addresses the critical need for a
clinically-viable, sperm selection method that avoids technician error, cell trauma, oxidative stress, and DNA
damage while reflecting as much as possible the natural in vivo process.
This project is a new collaboration enabled through the CHRP opportunity. The project brings together
engineering and male and female fertility health researchers, and IVF treatment providers at the OVO Fertility
Clinic. This work will lead to: (1) a new understanding of the fundamental characteristics of human sperm
motility; (2) sperm transport modes and metrics as indicators of sperm viability; (3) the application of these
findings at the clinical-level to the benefit of infertile couples and offspring; (4) new commercialization
opportunities for Canadian industry; and (5) highly qualified personnel with the multidisciplinary skills needed
to develop next-generation fertility treatments.